OMGA
Price:
$0.786
Market Cap:
$43.52M
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-regulate the expression of HNF4a, a transcriptional master regulator as a potential way to restore liver-cell function in patients suffering from chronic liver diseases; to control the expression of genes that have been strongly linked to cell-growth inhibition in patients with diabetes and other conditions to restore the capacity for corneal regenera...[Read more]
Industry
Biotechnology
IPO Date
2021-07-30
Stock Exchange
NASDAQ
Ticker
OMGA
According to Omega Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 141.27M. This represents a change of -32.75% compared to the average of 210.07M of the last 4 quarters.
The mean historical Enterprise Value of Omega Therapeutics, Inc. over the last ten years is 470.39M. The current 141.27M Enterprise Value has changed 2.90% with respect to the historical average. Over the past ten years (40 quarters), OMGA's Enterprise Value was at its highest in in the June 2021 quarter at 637.01M. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.
Average
470.39M
Median
374.89M
Minimum
222.56M
Maximum
774.99M
Discovering the peaks and valleys of Omega Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Enterprise Value = 774.99M
Minimum Annual Increase = -50.29%
Minimum Annual Enterprise Value = 222.56M
Year | Enterprise Value | Change |
---|---|---|
2023 | 222.56M | -1.25% |
2022 | 225.36M | -39.88% |
2021 | 374.89M | -50.29% |
2020 | 754.15M | -2.69% |
The current Enterprise Value of Omega Therapeutics, Inc. (OMGA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
274.27M
5-year avg
470.39M
10-year avg
470.39M
Omega Therapeutics, Inc.’s Enterprise Value is greater than PMV Pharmaceuticals, Inc. (47.77M), greater than Eliem Therapeutics, Inc. (119.64M), greater than MediciNova, Inc. (-41974173594.00), less than Pharvaris N.V. (850.00M), greater than PepGen Inc. (120.50M), less than Olema Pharmaceuticals, Inc. (468.89M), greater than Nuvectis Pharma, Inc. (81.37M), less than Larimar Therapeutics, Inc. (363.34M), less than Centessa Pharmaceuticals plc (1.75B), less than Orchestra BioMed Holdings, Inc. (195.57M), greater than Aerovate Therapeutics, Inc. (46.23M), less than Enliven Therapeutics, Inc. (1.10B), less than MoonLake Immunotherapeutics (3.05B), less than Structure Therapeutics Inc. (1.75B), less than Compass Therapeutics, Inc. (182.75M), less than Mineralys Therapeutics, Inc. (523.81M), greater than Cadrenal Therapeutics, Inc. Common Stock (20.50M),
Company | Enterprise Value | Market cap |
---|---|---|
47.77M | $83.31M | |
119.64M | $342.68M | |
-41974173594.00 | $104.47M | |
850.00M | $1.20B | |
120.50M | $143.75M | |
468.89M | $503.07M | |
81.37M | $98.54M | |
363.34M | $393.05M | |
1.75B | $2.06B | |
195.57M | $219.34M | |
46.23M | $76.81M | |
1.10B | $1.20B | |
3.05B | $3.43B | |
1.75B | $1.91B | |
182.75M | $205.01M | |
523.81M | $621.09M | |
20.50M | $24.86M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Omega Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Omega Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Omega Therapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Omega Therapeutics, Inc. (OMGA)?
What is the 3-year average Enterprise Value for Omega Therapeutics, Inc. (OMGA)?
What is the 5-year average Enterprise Value for Omega Therapeutics, Inc. (OMGA)?
How does the current Enterprise Value for Omega Therapeutics, Inc. (OMGA) compare to its historical average?